Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
54.77
-2.41 (-4.21%)
At close: Apr 28, 2026, 4:00 PM EDT
54.23
-0.54 (-0.99%)
After-hours: Apr 28, 2026, 5:41 PM EDT
Spruce Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | - | 4.91 | 10.09 | - | - | |
| Revenue Growth (YoY) | - | -51.32% | - | - | - | |
| Cost of Revenue | 13.62 | 46.42 | 49.43 | 35.2 | - | |
| Gross Profit | -13.62 | -41.51 | -39.34 | -35.2 | - | |
| Selling, General & Admin | 14.99 | 14.64 | 12.65 | 12.09 | 11.37 | |
| Research & Development | - | - | - | - | 30.7 | |
| Operating Expenses | 14.99 | 14.64 | 12.65 | 12.09 | 42.07 | |
| Operating Income | -28.61 | -56.15 | -51.99 | -47.28 | -42.07 | |
| Interest Expense | -0.09 | -0.31 | -0.48 | -0.42 | -0.35 | |
| Interest & Investment Income | 1.14 | 3.42 | 4.56 | 1.52 | 0.12 | |
| Other Non Operating Income (Expenses) | -3.5 | - | - | - | - | |
| EBT Excluding Unusual Items | -31.07 | -53.04 | -47.92 | -46.18 | -42.29 | |
| Merger & Restructuring Charges | -0.9 | - | - | - | - | |
| Legal Settlements | -1.9 | - | - | - | - | |
| Other Unusual Items | -5.1 | - | - | - | - | |
| Pretax Income | -38.97 | -53.04 | -47.92 | -46.18 | -42.29 | |
| Net Income | -38.97 | -53.04 | -47.92 | -46.18 | -42.29 | |
| Net Income to Common | -38.97 | -53.04 | -47.92 | -46.18 | -42.29 | |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 0 | 0 | |
| Shares Change (YoY) | 39.34% | 7.14% | 63.68% | 0.71% | 289.93% | |
| EPS (Basic) | -50.83 | -96.40 | -93.32 | -147.21 | -135.78 | |
| EPS (Diluted) | -50.83 | -96.40 | -93.32 | -147.21 | -135.78 | |
| Free Cash Flow | -33.33 | -55.96 | -33.28 | -41.69 | -35.97 | |
| Free Cash Flow Per Share | -43.47 | -101.73 | -64.82 | -132.90 | -115.48 | |
| Operating Margin | - | -1143.37% | -515.34% | - | - | |
| Profit Margin | - | -1079.94% | -474.96% | - | - | |
| Free Cash Flow Margin | - | -1139.56% | -329.88% | - | - | |
| EBITDA | -28.59 | -56.11 | -51.92 | -47.21 | -42 | |
| D&A For EBITDA | 0.02 | 0.05 | 0.07 | 0.07 | 0.07 | |
| EBIT | -28.61 | -56.15 | -51.99 | -47.28 | -42.07 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.